SERAC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.721200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.039800E-01
Normal-vs-Stage2
4.770800E-01
Normal-vs-Stage3
3.073600E-01
Normal-vs-Stage4
3.878600E-01
Stage1-vs-Stage2
7.280200E-01
Stage1-vs-Stage3
2.330800E-01
Stage1-vs-Stage4
4.042200E-01
Stage2-vs-Stage3
1.981620E-01
Stage2-vs-Stage4
2.022100E-02
Stage3-vs-Stage4
1.755840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.673400E-01
Normal-vs-AfricanAmerican
3.101800E-01
Normal-vs-Asian
3.160600E-01
Caucasian-vs-AfricanAmerican
8.500200E-01
Caucasian-vs-Asian
6.985800E-01
AfricanAmerican-vs-Asian
9.417000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.705000E-01
Normal-vs-Female
4.763400E-01
Male-vs-Female
9.081800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.754200E-01
Normal-vs-Age(41-60Yrs)
1.743630E-01
Normal-vs-Age(61-80Yrs)
4.509200E-01
Normal-vs-Age(81-100Yrs)
3.759200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.686600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.922010E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.034790E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.672750E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.449590E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.269800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.185200E-01
Normal-vs-Daily Drinker
3.540400E-01
Normal-vs-Weekly Drinker
4.634600E-01
Normal-vs-Occasional Drinker
1.848010E-01
Normal-vs-Social Drinker
5.480600E-01
Non Drinker-vs-Daily Drinker
4.807700E-02
Non Drinker-vs-Weekly Drinker
6.165400E-01
Non Drinker-vs-Occasional Drinker
6.603800E-01
Non Drinker-vs-Social Drinker
8.303600E-01
Daily Drinker-vs-Weekly Drinker
1.851960E-01
Daily Drinker-vs-Occasional Drinker
2.185400E-01
Daily Drinker-vs-Social Drinker
4.190200E-02
Weekly Drinker-vs-Occasional Drinker
9.651200E-01
Weekly Drinker-vs-Social Drinker
5.059200E-01
Occasional Drinker-vs-Social Drinker
5.782800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.035000E-01
Normal-vs-Grade 2
2.719800E-01
Normal-vs-Grade 3
2.035200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.247400E-01
Grade 1-vs-Grade 3
8.275000E-01
Grade 1-vs-Grade 4
3.035000E-01
Grade 2-vs-Grade 3
3.985600E-01
Grade 2-vs-Grade 4
2.719800E-01
Grade 3-vs-Grade 4
2.035200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.224810E-01
Normal-vs-NonDiabetic
4.647800E-01
Diabetic-vs-NonDiabetic
8.869600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.232800E-01
Normal-vs-NoPancreatitis
4.688000E-01
Pancreatitis-vs-NoPancreatitis
5.787400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.202200E-01
Normal-vs-N1
4.942800E-01
N0-vs-N1
1.160010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.430200E-01
Normal-vs-TP53-NonMutant
6.424800E-01
TP53-Mutant-vs-TP53-NonMutant
1.233870E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
